OTC Watch

All stocks / PALX

Palomino Laboratories Inc. PALX

Palomino Laboratories (PALX): shares outstanding up 47% in a year and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated float OTCQBCalifornia, USA
Live quote on OTC Markets

Market listing

Full name
PALOMINO LABORATORIES INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 16
Website
www.palex.com
Source: Stockwatch, 2026-11-17

News headlines

Palomino Laboratories Appoints NBA Champion Tristan Thompson to its Strategic Advisory Board
2026-11-17 07:00 · News Release
Palomino Laboratories to Participate in the Stifel Deep Tech Forum on December 7, 2026
2026-11-10 07:00 · News Release
Palomino Laboratories Inc. Receives Its First Commercial Purchase Order from a Hyperscaler Customer For GaN MicroLED Communication Chips Supporting AI Optical Interconnects
2026-10-22 07:00 · News Release
Palomino Laboratories Co-Founder Steven DenBaars to Present at MicroLED Connect 2026
2026-09-15 07:00 · News Release
Palomino Laboratories to Participate in the 7th Annual Needham Virtual Semiconductor & SemiCap Conference on August 20, 2026
2026-08-13 07:00 · News Release
Palomino Laboratories Inc. Introduces New Digital Experience for Customers and Partners
2026-08-11 07:00 · News Release
Palomino Laboratories Completes Vega Links Acquisition and Strengthens Technology Leadership to Accelerate Next-Generation AI Interconnect Development
2026-08-03 07:00 · News Release
Palomino Laboratories Inc. Ships First Generation MicroLED Light Engine Prototypes to First Hyperscaler Customer
2026-07-22 07:00 · News Release
Palomino Laboratories Announces Binding LOI to Acquire Vega Links Inc. to Create a Next-Generation AI Interconnect Company
2026-07-16 07:00 · News Release
Palomino Laboratories Common Stock Commences Trading on the OTCQB VENTURE MARKET
2026-07-13 00:16 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Net loss
($3,163,196)
What it means

It spends more than it earns

Under strain

The company lost $3.2 million in the year. It reported no sales.

The report says
Cash and cash equivalents
$8,121,445
Net cash used in operating activities
($1,284,949)
What it means

It has cash for a while

Steady

It had $8.1 million in the bank and used about $107,079 a month. At that pace the money lasts about 76 months unless it borrows or sells more shares.

The report says
Total assets
$8,434,145
Total liabilities
$336,458
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $8.4 million. Its debts and unpaid bills add up to $336,458. That is about $0.04 owed for every $1 owned.

What this adds up to

1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-11-13

Shares outstanding rose from 18,770,686 (2025-11-14) to 27,636,539 (2026-11-13), up 47%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-11-13

Estimated float about 23,991,539 shares as of 2026-11-13: 27,636,539 outstanding minus 3,645,000 held by 2 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-11-14
18.8M
2025-12-31
18.8M
2026-03-31
18.9M
2026-05-15
23.2M
2026-06-30
23.2M
2026-08-04
27.6M
2026-09-30
27.6M
2026-11-13
27.6M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-13 10-Q10-Q
2026-11-06 8-K8-K
2026-10-14 8-K/A8-K/A
2026-10-08 DEF 14ADEF 14A
2026-09-28 PRE 14APRE 14A
2026-08-21 SCHEDULE 13D/A
2026-08-05 10-Q10-Q
2026-08-05 8-K8-K
2026-08-04 44
2026-07-16 8-K8-K
2026-05-15 10-Q10-Q
2026-05-05 8-K8-K

Common questions about PALX

Does PALX file reports with the SEC?

Yes. Palomino Laboratories files with the SEC under company number 0001938569. The most recent filing we hold is a 10-Q dated 2026-11-13.

Source record

How many PALX shares are outstanding?

27,636,539 shares as of 2026-11-13, as reported to the SEC. That is up 47% from 18,770,686 on 2025-11-14.

Source record

Has PALX filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Who runs Palomino Laboratories?

Officers named in its insider filings: Richard Ogawa (Secretary).

Source record

Is Palomino Laboratories making money?

The company lost $3.2 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record